Publications in collaboration with researchers from Centro de Investigación Médica Aplicada (19)

2025

  1. Intraperitoneal administration of mRNA encoding interleukin-12 for immunotherapy in peritoneal carcinomatosis

    Journal of Nanobiotechnology , Vol. 23, Núm. 1

  2. Intratumoral administration of Hibiscus sabdariffa-derived anthocyanins exerts potent antitumor effects in murine cancer models

    Frontiers in Immunology, Vol. 16

  3. Liposomal encapsulation of cholecalciferol mitigates in vivo toxicity and delays tumor growth

    Frontiers in Immunology, Vol. 16

2024

  1. Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C

    Journal for ImmunoTherapy of Cancer, Vol. 12, Núm. 4

  2. Peritoneal carcinomatosis in mouse models

    Methods in Cell Biology (Academic Press Inc.), pp. 67-78

2023

  1. Intratumoral injection of IL-12-encoding mRNA targeted to CSFR1 and PD-L1 exerts potent anti-tumor effects without substantial systemic exposure

    Molecular Therapy - Nucleic Acids, Vol. 33, pp. 599-616

2021

  1. Statins act as transient type i interferon inhibitors to enable the antitumor activity of modified vaccinia Ankara viral vectors

    Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 7

2020

  1. Insulin Fused to Apolipoprotein A-I Reduces Body Weight and Steatosis in DB/DB Mice

    Frontiers in Pharmacology, Vol. 11

  2. Long-Term Liver Expression of an Apolipoprotein A-I Mimetic Peptide Attenuates Interferon-Alpha-Induced Inflammation and Promotes Antiviral Activity

    Frontiers in Immunology, Vol. 11

  3. Scavenger Receptor Class B Type I is Required for 25-Hydroxycholecalciferol Cellular Uptake and Signaling in Myeloid Cells

    Molecular Nutrition and Food Research, Vol. 64, Núm. 15

2019

  1. Treatment of experimental autoimmune encephalomyelitis by sustained delivery of low-dose IFN-a

    Journal of Immunology, Vol. 203, Núm. 3, pp. 696-704

2015

  1. Liver-directed gene therapy of chronic hepadnavirus infection using interferon alpha tethered to apolipoprotein A-I

    Journal of Hepatology, Vol. 63, Núm. 2, pp. 329-336

  2. Overexpression of apolipoprotein A-I fused to an anti-transforming growth factor beta peptide modulates the tumorigenicity and immunogenicity of mouse colon cancer cells

    Cancer Immunology, Immunotherapy, Vol. 64, Núm. 6, pp. 717-725

2014

  1. Harnessing high density lipoproteins to block transforming growth factor beta and to inhibit the growth of liver tumor metastases

    PLoS ONE, Vol. 9, Núm. 5

2012

  1. A Semliki Forest virus vector engineered to express IFNα induces efficient elimination of established tumors

    Gene Therapy, Vol. 19, Núm. 3, pp. 271-278

  2. Kinetic and dynamic computational model-based characterization of new proteins in mice: Application to interferon alpha linked to apolipoprotein A-I

    PLoS ONE, Vol. 7, Núm. 7

  3. The fusion protein of IFN-α and apolipoprotein A-I crosses the blood-brain barrier by a saturable transport mechanism

    Journal of Immunology, Vol. 188, Núm. 8, pp. 3988-3992

2011

  1. Anchoring interferon alpha to apolipoprotein A-I reduces hematological toxicity while enhancing immunostimulatory properties

    Hepatology, Vol. 53, Núm. 6, pp. 1864-1873

  2. Successful colon cancer eradication after chemoimmunotherapy is associated with profound phenotypic change of intratumoral myeloid cells

    Journal of Immunology, Vol. 186, Núm. 2, pp. 807-815